In vivo magnetic resonance imaging of Amyloid-β plaques in mice

Methods in Molecular Biology

Volumn 849, Issue , 2012, Pages 435-451

  Wadghiri, Youssef Zaim ^a   Hoang, Dung Minh ^a   Wisniewski, Thomas ^a   Sigurdsson, Einar M ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

2D; 3D; Amyloid burden; Amyloid deposits; Amyloidosis; Contrast agent; Molecular imaging; Mouse; MRI; Susceptibility; Transgenic

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; GADOPENAMIDE; MANNITOL; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; CONTRAST MEDIUM; DIAGNOSTIC AGENT; GADOLINIUM; PUTRESCINE;

ALZHEIMER DISEASE; AMYLOIDOSIS; ANATOMICAL VARIATION; ANESTHESIA INDUCTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTIFACT REDUCTION; BLOOD BRAIN BARRIER; BRAIN; BRAIN AMYLOIDOSIS; BRAIN MAPPING; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FUNCTIONAL NEUROIMAGING; HISTOLOGY; IMMOBILIZATION; IN VIVO STUDY; LONGITUDINAL STUDY; MAGNETIC FIELD; MOLECULAR PROBE; MOTION ANALYSIS SYSTEM; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; RADIOFREQUENCY; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; AMYLOID PLAQUE; ANIMAL; CHEMISTRY; HUMAN; METABOLISM; METHODOLOGY; PATHOLOGY; STAINING; THREE DIMENSIONAL IMAGING;

AMYLOID BETA-PEPTIDES; ANIMALS; BRAIN; CONTRAST MEDIA; GADOLINIUM; HUMANS; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; MANNITOL; MICE; MICE, TRANSGENIC; PLAQUE, AMYLOID; PUTRESCINE; STAINING AND LABELING;

EID: 84864575680     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-61779-551-0_30     Document Type: Article

References (42)

1. Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, Yang F , et al. Correlative memory defi cits, Abeta elevation, and amyloid plaques in transgenic mice. Science (New York, NY) 1996, 274: 99-102
2. Holcomb L, Gordon MN, McGowan E, Yu X, Benkovic S, Jantzen P, Wright K , et al. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat Med 1998, 4: 97-100
3. McGowan E, Eriksen J, Hutton M. A decade of modeling Alzheimer's disease in transgenic mice. Trends Genet 2006, 22: 281-289
4. Ashe KH, Zahs KR. Probing the biology of Alzheimer's disease in mice. Neuron 2010, 66: 631-645
5. Obulesu M, Rao DM. Animal models of Alzheimer's disease: an understanding of pathology and therapeutic avenues. The International Journal of Neuroscience 2010, 120: 531-537
6. Wisniewski T, Sigurdsson EM. Murine models of Alzheimer's disease and their use in developing immunotherapies. Biochimica et Biophysica Acta 2010, 1802: 847-859
7. Benveniste H, Einstein G, Kim KR, Hulette C, Johnson GA. Detection of neuritic plaques in Alzheimer's disease by magnetic resonance microscopy. Proc. Natl. Acad. Sci. of the United States of America 1999, 96: 14079-14084
8. Dhenain M, Privat N, Duyckaerts C, Jacobs RE. Senile plaques do not induce susceptibility effects in T2-weighted MR microscopic images. NMR Biomed 2002, 15: 197-203
9. Poduslo JF, Wengenack TM, Curran GL, Wisniewski T, Sigurdsson EM, Macura SI, Borowski BJ , et al. Molecular targeting of Alzheimer's amyloid plaques for contrastenhanced magnetic resonance imaging. Neurobiol Dis 2002, 11: 315-329
10. Helpern JA, Lee SP, Falangola MF, Dyakin VV, Bogart A, Ardekani B, Duff K , et al. MRI assessment of neuropathology in a transgenic mouse model of Alzheimer's disease. Magn Reson Med 2004, 51: 794-798
11. Lee SP, Falangola MF, Nixon RA, Duff K, Helpern JA. Visualization of beta-amyloid plaques in a transgenic mouse model of Alzheimer's disease using MR microscopy without contrast reagents. Magn Reson Med 2004, 52: 538-544
12. Zhang J, Yarowsky P, Gordon MN, Di Carlo G, Munireddy S, van Zijl PC, Mori S. Detection of amyloid plaques in mouse models of Alzheimer's disease by magnetic resonance imaging. Magn Reson Med 2004, 51: 452-457
13. Dhenain M, Delatour B, Walczak C, Volk A. Passive staining: A novel ex vivo MRI protocol to detect amyloid deposits in mouse models of Alzheimer's disease. Magn Reson Med 2006, 55: 687-693
14. Sigurdsson EM, Wadghiri YZ, Mosconi L, Blind JA, Knudsen E, Asuni A, Scholtzova H , et al. A non-toxic ligand for voxel-based MRI analysis of plaques in AD transgenic mice. Neurobiol Aging 2008, 29: 836-847
15. Wadghiri YZ, Sigurdsson EM, Sadowski M, Elliott JI, Li Y, Scholtzova H, Tang CY , et al. Detection of Alzheimer's amyloid in transgenic mice using magnetic resonance microimaging. Magn Reson Med 2003, 50: 293-302
16. Jack CR, Jr., Garwood M, Wengenack TM, Borowski B, Curran GL, Lin J, Adriany G , et al. In vivo visualization of Alzheimer's amyloid plaques by magnetic resonance imaging in transgenic mice without a contrast agent. Magn Reson Med 2004, 52: 1263-1271
17. Jack CR, Jr., Wengenack TM, Reyes DA, Garwood M, Curran GL, Borowski BJ, Lin J , et al. In vivo magnetic resonance microimaging of individual amyloid plaques in Alzheimer's transgenic mice. J Neurosci 2005, 25: 10041-10048
18. Sigurdsson EM, Wadghiri YZ, Sadowski M, Elliott JI, Li Y, Scholtzova H, Tang CY , et al. In vivo magnetic resonance of amyloid plaques in Alzheimer's disease model mice. In: Hyman B, Demonet JF, Christen Y eds., The living brain and Alzheimer's disease Hardcover ed. Berlin: Springer Verlag 2004: 47-59
19. Higuchi M, Iwata N, Matsuba Y, Sato K, Sasamoto K, Saido TC. 19F and 1H MRI detection of amyloid beta plaques in vivo. Nat Neurosci 2005, 8: 527-533
20. Vanhoutte G, Dewachter I, Borghgraef P, Van Leuven F, Van der Linden A. Noninvasive in vivo MRI detection of neuritic plaques associated with iron in APP(V717I) transgenic mice, a model for Alzheimer's disease. Magn Reson Med 2005, 53: 607-613
21. Braakman N, Matysik J, van Duinen SG, Verbeek F, Schliebs R, de Groot HJ, Alia A. Longitudinal assessment of Alzheimer's betaamyloid plaque development in transgenic mice monitored by in vivo magnetic resonance microimaging. J Magn Reson Imaging 2006, 24: 530-536
22. Borthakur A, Gur T, Wheaton AJ, Corbo M, Trojanowski JQ, Lee VM, Reddy R. In vivomeasurement of plaque burden in a mouse model of Alzheimer's disease. J Magn Reson Imaging 2006, 24: 1011-1017
23. Faber C, Zahneisen B, Tippmann F, Schroeder A, Fahrenholz F. Gradient-echo and CRAZED imaging for minute detection of Alzheimer plaques in an APPV717I x ADAM10-dn mouse model. Magn Reson Med 2007, 57: 696-703
24. Muskulus M, Scheenstra AE, Braakman N, Dijkstra J, Verduyn-Lunel S, Alia A, de Groot HJ , et al. Prospects for early detection of Alzheimer's disease from serial MR images in transgenic mice. Current Alzheimer Research 2009, 6: 503-518
25. Scholtzova H, Wadghiri YZ, Douadi M, Sigurdsson EM, Li YS, Quartermain D, Banerjee P , et al. Memantine leads to behavioral improvement and amyloid reduction in Alzheimer's-disease-model transgenic mice shown as by micromagnetic resonance imaging. Journal of Neuroscience Research 2008, 86: 2784-2791
26. Yang J, Zaim Wadghiri Y, Minh Hoang D, Tsui W, Sun Y, Chung E, Li Y , et al. Detection of amyloid plaques targeted by USPIOAbeta1-42 in Alzheimer's disease transgenic mice using magnetic resonance microimaging. Neuroimage 2011, 55(4): 1600-1609
27. Weinmann HJ, Brasch RC, Press WR, Wesbey GE. Characteristics of gadolinium-DTPA complex: A potential NMR contrast agent. AJR Am J Roentgenol 1984b, 142: 619-624
28. Weinmann HJ, Laniado M, Mutzel W. Pharmacokinetics of GdDTPA/dimeglumine after intravenous injection into healthy volunteers. Physiological chemistry and physics and medical NMR 1984a, 16: 167-172
29. Bulte JW, Kraitchman DL. Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed 2004, 17: 484-499
30. Mulder WJ, Griffi oen AW, Strijkers GJ, Cormode DP, Nicolay K, Fayad ZA. Magnetic and fl uorescent nanoparticles for multimodality imaging. Nanomedicine (London, England) 2007, 2: 307-324
31. Siddiqui TS, Jani A, Williams F, Muller RN, Vander Elst L, Laurent S, Yao F , et al. Lanthanide complexes on Ag nanoparticles: designing contrast agents for magnetic resonance imaging. Journal of Colloid and Interface Science 2009, 337: 88-96
32. Wadghiri YZ, Briley-Saebo K. Nanobiomaterials for Preclinical Studies and Clinical Diagnostic. In: Sitharaman B ed., Nanobiomaterials Handbook Hardback ed. New York: CRC Press. 2011: 1-24
33. Johnson G, Zaim Wadghiri Y, Turnbull DH. Sensitivity in 2D multislice and 3D MR imaging. Magn Reson Med 2003, 49(5): 848-855
34. Hoult DI, Richards RE. The signal-to-noise ratio of the nuclear magnetic resonance experiment. J Magn Reson 1976: 71-85
35. Hayes CE, Edelstein WA, Schenck JF, O.M. M, Eash M. An effi cient, highly homogeneous radiofrequency coil for whole-body NMR imaging at 1.5T. J Mag Reson 1985, 63: 622-628
36. Glover GH, Hayes CE, Pelc NJ, Edelstein WA, Mueller OM, Hart HR, O'Donnell M , et al. Comparison of linear and circular polarization for magnetic resonance imaging. J Mag Reson 1985, 64: 255-270
37. Doty FD, Entzminger G, Jr., Hauck CD. Errortolerant RF litz coils for NMR/MRI. J Magn Reson 1999, 140: 17-31
38. Crooks LE, Ortendahl DA, Kaufman L, Hoenninger J, Arakawa M, Watts J, Cannon CR , et al. Clinical effi ciency of nuclear magnetic resonance imaging. Radiology 1983, 146: 123-128
39. Crooks L, Arakawa M, Hoenninger J, Watts J, McRee R, Kaufman L, Davis PL , et al. Nuclear magnetic resonance whole-body imager operating at 3.5 KGauss. Radiology 1982, 143: 169-174
40. Brunner P, Ernst RR. Sensitivity and performance time in NMR imaging. J Magn Reson 1979: 83-106
41. Johnson G, Wadghiri YZ, Turnbull DH. 2D multislice and 3D MRI sequences are often equally sensitive. Magn Reson Med 1999, 41: 824-828
42. Jack CR, Jr., Marjanska M, Wengenack TM, Reyes DA, Curran GL, Lin J, Preboske GM , et al. Magnetic resonance imaging of Alzheimer's pathology in the brains of living transgenic mice: A new tool in Alzheimer's disease research. Neuroscientist 2007, 13: 38-48